Jeffrey P. Brosco, M.D., Ph.D., professor of clinical pediatrics and associate director of the Mailman Center for Child Development at the University of Miami Miller School of Medicine, has been named Florida's Deputy Secretary for Children's Medical Services (CMS). Brosco will oversee the Division of Children's Medical Services and the Office of the CMS Managed Care Plan and Specialty Programs.
New Ethics Guidelines for Gene Editing 08.03.2017
On August 3, The American Journal of Human Genetics published the American Society for Human Genetics’ policy statement on germline gene editing in humans. Representing the Miller School on the task force was Rosario Isasi, J.D., M.P.H., a bioethicist and lawyer whose work focuses on the regulation of human genetic technologies. We asked Isasi to discuss the policy statement and its broad implications.
David Sinclair, M.D., M.B.A., associate professor of anesthesiology, has been named Chief Patient Safety and Quality Officer of the University of Miami Health System, a position he has filled on an interim basis since November. He will provide strategic leadership of mandatory quality programs, focused attention to value-based care, support to a performance improvement system, and commitment to a system-wide culture of safety.
Graduate School Dean Guillermo “Willy” Prado, Ph.D., an internationally known expert in effective intervention strategies for at-risk youth, has been named a “research exemplar” by The Research Exemplar Project at Washington University School of Medicine. Prado is the Leonard M. Miller Professor of Public Health Sciences and director of the Division of Prevention Science and Community Health.
Amid pomp and circumstance, plus some red carpet flair, this year’s chief surgical residents celebrated their graduations from the General Surgery Training Program at the University of Miami Miller School of Medicine’s DeWitt Daughtry Family Department of Surgery.
An iconic group of Sports Legends, Hall of Famers, Gold Medalists, World Champions, and other honorees will be recognized by The Buoniconti Fund to Cure Paralysis, the fundraising arm of The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine, at its 32nd Annual Great Sports Legends Dinner presented by Tudor Group on Monday, September 25, at The New York Hilton Midtown Hotel.
The Personalized Medicine Coalition (PMC), a prestigious group representing innovators, scientists, patients, providers and payers, has invited Sylvester Comprehensive Cancer Center to join its membership. “The invitation signifies their recognition of our strong work in this area,” said Jonathan C. Trent, M.D., Ph.D., Sylvester’s director of precision medicine.
It was on June 7 that Helen Peck, M.A., executive director of clinical research services at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, received the exciting news that she was being invited to make an oral presentation at the 9th Annual Clinical Research Meeting of the Association of American Cancer Institutes in Chicago.
Long-term results of the first-ever gene therapy clinical trial in the U.S. for a mitochondrial disease, Leber Hereditary Optic Neuropathy, showed low and medium doses improved visual acuity in most patients when treated within one year of onset of visual loss. The study was conducted at Bascom Palmer Eye Institute.
The Miami Dolphins and UHealth – the University of Miami Health System announced a partnership that will see the local health system serve as the official health care provider of the Miami Dolphins and Hard Rock Stadium. Through the partnership, UHealth will have the entitlement to the southeast corner of Hard Rock Stadium.